col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


60 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Thrombosis Journal
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―21 Syndecan-1 as a prognostic biomarker in COVID-19 patients: a retrospective study of a Japanese cohort Kiyohito Hayashi, Daisuke Koyama, Yoichi Hamazaki, Takamichi Kamiyama, Shingo Yamada, Miki Furukawa, et al. (+3)
2 [GO] 2024―Jan―04 Association between antithrombotic therapy and mortality in patients hospitalized for COVID-19 Xing Wang, Wuqian Chen, Jiulin Guo, Xingyu Qiu, Chao You, Lu Ma
3 [GO] 2023―Oct―02 A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19 Sandra Jonmarker, Jacob Litorell, Felix Alarcon, Kais Al-Abani, Sofia Björkman, Maria Farm, et al. (+10)
4 [GO] 2023―Sep―07 A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection Hao Tang, Yan Yan
5 [GO] 2023―Sep―06 Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais Kochawan Boonyawat, Tichayapa Phojanasenee, Phichchapha Noikongdee, Pornnapa Police, Pichika Chantrathammachart, Pimjai Niparuck, et al. (+3)
6 [GO] 2023―Aug―23 Correction: Predictors of pulmonary embolism in hospitalized patients with COVID-19 Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul Ain Baloch, Jiafang Zhang, et al. (+3)
7 [GO] 2023―Jul―28 Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study Emily Corneo, Rafael Garbelotto, Gabriele Prestes, Carolina Saibro Girardi, Lucas Santos, Jose Claudio Fonseca Moreira, et al. (+6)
8 [GO] 2023―Jul―03 Predictors of pulmonary embolism in hospitalized patients with COVID-19 Jeeyune Bahk, Abdul Rehman, Kam Sing Ho, Bharat Narasimhan, Hafiza Noor Ul, Ain Baloch, et al. (+4)
9 [GO] 2023―May―25 Clinical characteristics of COVID-19 associated vasculopathic diseases Thiemo Greistorfer, Philipp Jud
10 [GO] 2023―May―02 How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores Jakob Vielhauer, Christopher Benesch, Anna Pernpruner, Anna-Lena Johlke, Johannes Christian Hellmuth, Maximilian Muenchhoff, et al. (+7)
11 [GO] 2023―Apr―18 Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study Pauline Lamouche-Wilquin, Léa Perrin, Morgane Pere, Matthieu Raymond, Pierre Asfar, Cedric Darreau, et al. (+14)
12 [GO] 2023―Jan―30 Low dose ultra-slow infusion thrombolytic therapy (LDUSITT) as an alternative option in a COVID-19 patient with free-floating right atrial thrombus: a case report and review of literature Mahsa Mahjani, Sepehr Gohari, Hassan Ahangar
13 [GO] 2023―Jan―30 Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic Mohamed S. Zaghloul, Momodou Jammeh, Andrew Gibson, Suhong Luo, Kelley Chadwick-Mansker, Qianjin Liu, et al. (+2)
14 [GO] 2023―Jan―02 A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time Ruben Siedlarczyk Nogueira, Bruno Ramos Salu, Vinícius Goulart Nardelli, Camila Ramalho Bonturi, Marina Rodrigues Pereira, Francisco Humberto de Abreu Maffei, et al. (+2)
15 [GO] 2022―Dec―08 Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, et al. (+15)
16 [GO] 2022―Sep―26 The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia Dominik F. Draxler, Justine Brodard, Björn Zante, Stephan M. Jakob, Jan Wiegand, Johanna A. Kremer Hovinga, et al. (+2)
17 [GO] 2022―Sep―20 Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study Junichi Nakamura, Ichizo Tsujino, Sen Yachi, Makoto Takeyama, Yuji Nishimoto, Satoshi Konno, et al. (+18)
18 [GO] 2022―Sep―13 Correction: Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia Alessandro Bosi, Wilma Barcellini, Bruno Fattizo
19 [GO] 2022―Aug―29 Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study Lars Heubner, Marvin Greiner, Oliver Vicent, Jan Beyer-Westendorf, Oliver Tiebel, Ute Scholz, et al. (+5)
20 [GO] 2022―Aug―23 Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis Hong Duo, Yahui Li, Yujie Sun, Liang Wei, Ziqing Wang, Fang Fang, et al. (+5)
21 [GO] 2022―Aug―23 Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia Bosi Alessandro, Barcellini Wilma, Fattizzo Bruno
22 [GO] 2022―Aug―22 Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report Marc Weiner, Robert Rodriguez-Vigouroux, Stavroula Masouridi-Levrat, Kaveh Samii
23 [GO] 2022―Jun―20 Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis Bruno Bais, Emanuela Sozio, Daniele De Silvestri, Stefano Volpetti, Maria Elena Zannier, Carla Filì, et al. (+12)
24 [GO] 2022―May―10 Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study Na Cui, Chunguo Jiang, Chenlu Yang, Liming Zhang, Xiaokai Feng
25 [GO] 2022―Mar―30 NETosis and SARS-COV-2 infection related thrombosis: a narrative review Mahin Behzadifard, Masoud Soleimani
26 [GO] 2022―Feb―14 The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study Syed Nabeel Muzaffar, Suhail Sarwar Siddiqui, Nilanchal Chakraborty, Afzal Azim
27 [GO] 2021―Dec―20 Incidence and characteristics of arterial thromboemboli in patients with COVID-19 Nancy Glober, Lauren Stewart, JangDong Seo, Christopher Kabrhel, Kristen Nordenholz, Carlos Camargo, Jeffrey Kline
28 [GO] 2021―Dec―15 Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review Mauricio Castillo-Perez, Carlos Jerjes-Sanchez, Alejandra Castro-Varela, Jose Gildardo Paredes-Vazquez, Eduardo Vazquez-Garza, Ray Erick Ramos-Cazares, et al. (+10)
29 [GO] 2021―Nov―24 Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis Sirui Zhang, Yupei Li, Guina Liu, Baihai Su
30 [GO] 2021―Nov―15 Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19 David Oliver Hamilton, Alexander Main-Ian, Jessie Tebbutt, Maya Thrasher, Alicia Waite, Ingeborg Welters
31 [GO] 2021―Nov―13 Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials Noppacharn Uaprasert, Krissana Panrong, Ponlapat Rojnuckarin, Thita Chiasakul
32 [GO] 2021―Nov―06 The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study Colette Neethling, Gregory Calligaro, Malcolm Miller, Jessica J. S. Opie
33 [GO] 2021―Nov―04 Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients Yael Lichter, Tanya Badelbayov, Irina Shalev, Reut Schvartz, Yishay Szekely, Dan Benisty, et al. (+9)
34 [GO] 2021―Sep―16 Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2 Kenji Yamamoto
35 [GO] 2021―Aug―23 Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity Mahin Behzadi Fard, Samaneh Behzadi Fard, Shahin Ramazi, Amir Atashi, Zahra Eslamifar
36 [GO] 2021―Aug―18 Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19 Rajiv Advani, Torbjørn Austveg Strømsnes, Espen Stjernstrøm, Sebastian T. Lugg
37 [GO] 2021―Aug―16 Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19 Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Takao Miyagawa, et al. (+8)
38 [GO] 2021―Jun―29 A review of thromboembolic events in hospitalized COVID-19 patients Paul Fontelo, Mrigendra M. Bastola, Zhaonian Zheng, Seo Hyon Baik
39 [GO] 2021―Jun―02 Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study Johannes Herrmann, Quirin Notz, Tobias Schlesinger, Jan Stumpner, Markus Kredel, Magdalena Sitter, et al. (+5)
40 [GO] 2021―Jun―02 Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study Sarah Galien, Michael Hultström, Miklós Lipcsey, Karl Stattin, Robert Frithiof, Jacob Rosén, et al. (+5)
41 [GO] 2021―May―31 Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort Mark M. G. Mulder, LIoyd Brandts, Renée A. G. Brüggemann, Marcel Koelmann, Alexander S. Streng, Renske H. Olie, et al. (+10)
42 [GO] 2021―May―19 Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis Xiaoming Xiong, Jianhua Chi, Qinglei Gao
43 [GO] 2021―May―12 Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report Ehsan Aghaei Moghadam, Shima Mahmoudi, Alieh Safari Sharari, Mehrnoush Afsharipour, Mojtaba Gorji, Amene Navaeian, et al. (+2)
44 [GO] 2021―Apr―20 An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study Fumihiro Ogawa, Yasufumi Oi, Kento Nakajima, Reo Matsumura, Tomoki Nakagawa, Takao Miyagawa, et al. (+2)
45 [GO] 2021―Mar―09 Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis Gregoire Longchamp, Sara Manzocchi-Besson, Alban Longchamp, Marc Righini, Helia Robert-Ebadi, Marc Blondon
46 [GO] 2021―Mar―08 Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore Chuen Wen Tan, Bingwen Eugene Fan, Winnie Z. Y. Teo, Moon Ley Tung, Humaira Shafi, Dheepa Christopher, et al. (+21)
47 [GO] 2021―Mar―03 High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study Abdulrahman Al Raizah, Ahmed Al Askar, Naila Shaheen, Khalid Aldosari, Mohamed Alnahdi, Musumadi Luhanga, et al. (+9)
48 [GO] 2021―Feb―11 Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients Kristina Boss, Andreas Kribben, Bartosz Tyczynski
49 [GO] 2021―Feb―10 Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients Tiebin Jiang, Bo Lv, Hongxia Liu, Shiwen He, Guogang Zhang, Chanyi Li, et al. (+17)
50 [GO] 2021―Jan―27 Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury Keiko Suzuki, Hideshi Okada, Hiroyuki Tomita, Kazuyuki Sumi, Yoshinori Kakino, Ryu Yasuda, et al. (+6)
51 [GO] 2021―Jan―06 Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization Franca Del Nonno, Daniele Colombo, Roberta Nardacci, Laura Falasca
52 [GO] 2020―Dec―29 Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavaj, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, et al. (+2)
53 [GO] 2020―Dec―15 Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor Zahra Eslamifar, Mahin Behzadifard, Masoud Soleimani, Saba Behzadifard
54 [GO] 2020―Dec―14 Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report Xuan T. Phan, Tuan H. Nguyen, Tung T. Tran, Thu-Hien T. Huynh, Thuy-Ha T. Hoang, Vinh-Chau V. Nguyen, Thao N. T. Pham
55 [GO] 2020―Nov―23 Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis Kochawan Boonyawat, Pichika Chantrathammachart, Pawin Numthavej, Nithita Nanthatanti, Sithakom Phusanti, Angsana Phuphuakrat, et al. (+2)
56 [GO] 2020―Oct―16 Coagulopathy associated with COVID-19 - Perspectives & Preventive strategies using a biological response modifier Glucan Nobunao Ikewaki, Kosagi-Sharaf Rao, Armando Durant Archibold, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, et al. (+2)
57 [GO] 2020―Sep―10 Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers Bassam Atallah, Wasim El Nekidy, Saad I. Mallah, Antoine Cherfan, Laila AbdelWareth, Jihad Mallat, Fadi Hamed
58 [GO] 2020―Sep―06 Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory M. Hardy, T. Lecompte, J. Douxfils, S. Lessire, J. M. Dogné, B. Chatelain, et al. (+7)
59 [GO] 2020―Sep―02 SARS-CoV-2 and pulmonary embolism: who stole the platelets? Michael Tran, Chirag Sheth, Rohan Bhandari, Scott J. Cameron, Deborah Hornacek
60 [GO] 2020―Apr―20 Thrombosis management in times of COVID-19 epidemy; a Dutch perspective Hugo ten Cate
 [1] 

60 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.011 sec